Education Events

2025 Post WFNOS / SNO Webinar​

2025-12-03

Hear expert insights with an Australian lens

Join us for an exclusive virtual post-conference update of the latest breakthroughs in brain cancer research and treatment from WFNOS / SNO 2025.

This insightful webinar will cover the latest breakthroughs in brain cancer research and treatment emerging from the 7th World Federation of Neuro-Oncology Societies (WFNOS) and 30th Society for Neuro-Oncology (SNO) Meetings in Honolulu, Hawaii.

Sponsored by

Chairs

Dr. Joseph Sia

Dr. Joseph Sia

Radiation Oncologist (VIC)

Joe Sia is a Radiation Oncologist in the Neuro-Oncology Unit at the Peter MacCallum Cancer Centre and a Senior Clinical Research Fellow at WEHI. He did his medical training in New Zealand, radiation oncology training and laboratory-based PhD in Australia. He leads the Neuro-Oncology Translational Radiobiology Research Programme, a collaboration between Peter Mac and WEHI.

Speakers

Dr. Saskia Freytag

Dr. Saskia Freytag

Laboratory Head (VIC)

Dr. Saskia Freytag is a laboratory head in the Personalised Oncology Division at the Walter and Eliza Hall Institute. She co-leads the Brain Cancer Research Laboratory at the Brain Cancer Centre and directs its bioinformatics work, where her team applies advanced single-cell and spatial omics technologies to enhance surgical approaches, uncover treatment resistance, and discover new therapeutic strategies. She holds a PhD in Statistical Genetics from Georg-August University and has completed postdoctoral work at WEHI and the Harry Perkins Institute of Medical Research. Beyond her scientific contributions, she is committed to community and inclusivity, having chaired the Bioconductor Project’s Code of Conduct Committee and served as an ambassador for the Australian Mathematical Science Institute’s CHOOSEMATHS program.

Dr. Andrew Gogos

Dr. Andrew Gogos

Neurosurgeon (VIC)

Dr. Andrew Gogos is a neurosurgeon from Melbourne with a sub specialist interest in neuro-oncology. After training in Australia, he completed a brain tumour fellowship at the University of California, San Francisco. He has published extensively on the surgical management of patients with glioma and was a co-convenor of the COGNO ASM in 2024.

Dr. Lukasz Klobukowski

Dr. Lukasz Klobukowski

Radiation Oncologist (AKL, NZ)

Dr. Lukasz Klobukowski is a Radiation Oncologist at Auckland City Hospital and ARO. With a background that includes a BSc in Computer Science, a medical degree and postgraduate diploma in Ophthalmology from the University of Otago, and fellowships through the Auckland Regional Cancer Centre and the Royal Marsden Hospital in London. His extensive clinical oncology experience spans neuro-oncology, head and neck, gastrointestinal and skin cancers, often within clinical trials, and he is skilled in advanced radiotherapy techniques such as stereotactic radiosurgery, CyberKnife, MR Linac and unsealed source therapy. He has a strong clinical interest in central nervous system tumours as well as head and neck, melanoma, gastrointestinal and oligometastatic cancers.

Dr. Marion Mateos

Dr. Marion Mateos

Paediatric Oncologist (NSW)

Dr. Marion K. Mateos is an early-career clinician researcher and paediatric oncologist, with a clinical focus on treatment of children with brain tumours. Her translational research profile is focused on early phase clinical trial development, application of liquid biopsy and biomarker development, as well as reducing treatment-related toxicities in children. She is the successful recipient of a Cancer Institute NSW Early Career Fellowship (2019-2023) and the inaugural Col Reynolds Clinical Fellowship from The Kids’ Cancer Project (2024-2027).

Dr. Jim Whittle

Dr. Jim Whittle

Medical Oncologist (VIC)

Dr. Jim Whittle is a Neuro-Oncologist at the Peter MacCallum Cancer Centre and Co-Head of the Brain Cancer Research Laboratory at WEHI. An emerging leader in Neuro-Oncology, he combines a deep understanding of basic biology with innovative drug development through patient-derived models and novel Phase 0 clinical trials. Dr. Whittle holds multiple leadership roles, including Co-Director of Research Strategy at the Brain Cancer Centre, Management Committee Member as well as Chair of the Outreach and Education Committee for COGNO, and member of the research advisory committee for the Mark Hughes Foundation Centre for Brain Cancer Research. He is also dedicated to enhancing care and clinical trial enrolment for Adolescents and Young Adults (AYAs) with brain tumours, and online survivorship and support initiatives like braintumoursonline.org (led together with Prof Kate Drummond at RMH).

Others Education Events

Education Events

2026-05-09
Brought to you by the COGNO Education Committee. ‘From Idea to Trial Concept’ is the first in a new series of COGNO skills development workshops, designed to build research capacity across the neuro-oncology community. This half-day workshop is aimed at those who are interested in developing a neuro-oncology clinical trial but are at the early stages of that journey. The session will take participants through the process of moving from an initial idea to a coherent, well-framed trial concept.

Education Events

2024-12-10
Join local neuro-oncology experts for a review of the latest and most significant international treatment and research findings in brain cancer presented at this year’s Society for Neuro-Oncology Meeting in Houston, Texas. Our expert panel will review the latest in translational science, and clinical updates in low grade glioma and glioblastoma. Drawing on a panel of clinicians and scientist from across Australia, this is a great opportunity to hear their perspectives on how these advances may impact brain cancer care in Australia.

Education Events

2025-05-24
Gliomas are the most common form of brain cancer in Australia. Implementing effective early detection and management strategies is essential to improving outcomes and enhancing the quality of life for those affected. This masterclass aims to provide clinicians and trainees with an in-depth, multidisciplinary understanding of current and emerging strategies in the management of low-grade glioma (LGG), with a focus on IDH-mutant gliomas, through expert-led lectures and interactive case-based discussions.

Your donations to our Brain Tumour research make a real difference